AXYS Pharmaceuticals Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AXYS Pharmaceuticals Inc.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: bob zagorin who wrote (348)	11/15/1999 11:10:00 AM
From: bob zagorin	Read Replies (1) of 455

after i bot, i found this. BioTech Stocks · Axys: Partnership Makes Buy Opportunity By Jim McCamant The company also announced that they have established a partnership with the San Diego-based, private biotech company Signal Pharmaceuticals. Under the terms of the deal, AXPH will gain exclusive worldwide rights to Signal's selective estrogen receptor-beta modulators to treat cancer. These compounds act on the beta subtype of the estrogen receptor, which is located on various types of cancer cells. In exchange for these rights, AXPH will pay an undisclosed licensing fee and make research payments to Signal... (con't) tfc.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next